Over-expression of neurotensin high-affinity receptor 1 (NTS1) in relation with its ligand neurotensin (NT) and nuclear β-catenin in inflammatory bowel disease-related oncogenesis

被引:27
作者
Bossard, Celine [1 ]
Souaze, Frederique
Jarry, Anne
Bezieau, Stephane
Mosnier, Jean-Francois
Forgez, Patricia
Laboisse, Christian L.
机构
[1] INSERM, U539, F-44035 Nantes, France
[2] Univ Nantes, Fac Med, F-44035 Nantes, France
[3] CHU Nantes, Serv Anat & Cytol Pathol, F-44035 Nantes, France
[4] UPMC, INSERM, U673, F-75571 Paris, France
[5] Fac Med, EA 3823, F-44035 Nantes, France
关键词
neurotensin high-affinity receptor 1; (NTS1); neurotensin (NT); inflammatory bowel disease; colorectal oncogenesis; APC/beta-catenin pathway;
D O I
10.1016/j.peptides.2007.06.030
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We investigated the expression of the neurotensin high-affinity receptor 1 (NTS1) during inflammatory bowel disease (IBD)-related colorectal oncogenesis, in colonic samples from 30 patients with IBD-related adenocarcinomas, dysplasias, and inflammatory mucosa (IM). The percentage of NTS1-positive epithelial cells progressively increased from the inflammatory condition to adenocarcinoma and was significantly higher in adenocarcinomas than in IM (p = 0.0169). In parallel, the percentage of neurotensin (NT)-positive epithelial cells increased during the IBD-related oncogenesis. Finally, as NTS1 is a beta-catenin inducible gene, we found that a number of preneoplastic lesions and adenocarcinomas co-expressed NTS1 and beta-catenin without NT expression. Therefore, this study suggests two pathways of NTS1 overexpression during IBD-related oncogenesis: one triggered by NT overexpression, and a second associated with an activation of the APC/beta-catenin pathway, these two pathways being not mutually exclusive. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:2030 / 2035
页数:6
相关论文
共 23 条
[1]   Altered distribution of β-catenin, and its binding proteins E-cadherin and APC, in ulcerative colitis-related colorectal cancers [J].
Aust, DE ;
Terdiman, TP ;
Willenbucher, RF ;
Chew, K ;
Ferrell, L ;
Florendo, C ;
Molinaro-Clark, A ;
Baretton, GB ;
Löhrs, U ;
Waldman, FM .
MODERN PATHOLOGY, 2001, 14 (01) :29-39
[2]  
Bernstein CN, 2001, CANCER-AM CANCER SOC, V91, P854, DOI 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO
[3]  
2-Z
[4]   Early functional effects of Clostridium difficile toxin A on human colonocytes [J].
Branka, JE ;
Vallette, G ;
Jarry, A ;
BouHanna, C ;
Lemarre, P ;
Van, PN ;
Laboisse, CL .
GASTROENTEROLOGY, 1997, 112 (06) :1887-1894
[5]   Neuropeptide neurotensin stimulates intestinal wound healing following chronic intestinal inflammation [J].
Brun, P ;
Mastrotto, C ;
Beggiao, E ;
Stefani, A ;
Barzon, L ;
Sturniolo, GC ;
Palù, G ;
Castagliuolo, I .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2005, 288 (04) :G621-G629
[6]   Involvement of neurotensin in cancer growth: Evidence, mechanisms and development of diagnostic tools [J].
Carraway, Robert E. ;
Plona, Ann M. .
PEPTIDES, 2006, 27 (10) :2445-2460
[7]   Neurotensin is a proinflammatory neuropeptide in colonic inflammation [J].
Castagliuolo, I ;
Wang, CC ;
Valenick, L ;
Pasha, A ;
Nikulasson, S ;
Carraway, RE ;
Pothoulakis, C .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (06) :843-849
[8]   Neurotensin and growth of normal and neoplastic tissues [J].
Evers, B. Mark .
PEPTIDES, 2006, 27 (10) :2424-2433
[9]  
Ferris C.F., 1989, HDB PHYSL, P559
[10]   A reproducible grading scale for histological assessment of inflammation in ulcerative colitis [J].
Geboes, K ;
Riddell, R ;
Öst, A ;
Jensfelt, B ;
Persson, T ;
Löfberg, R .
GUT, 2000, 47 (03) :404-409